Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Dyne Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 102 | 1 | 113 | +12 |
| Shares | 44.6M | 1.56K | 49.7M | +5.16M (+11.6%) |
| Value | $565.8M | $20.0K | $576.2M | +$10.4M (+1.8%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Dyne Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,322,384 | $26.9M | 0.82% |
| Braidwell LP | 753,145 | $8.73M | 0.29% |
| AXA S.A. | 368,785 | $4.27M | 0.02% |
| Norges Bank | 157,752 | $1.83M | 0.00% |
| Jane Street Group, LLC | 95,751 | $1.11M | 0.00% |
| Affinity Asset Advisors, LLC | 92,170 | $1.07M | 0.49% |
| Putnam Investments LLC | 39,818 | $461.5K | 0.00% |
| Caxton Associates LP | 36,360 | $421.4K | 0.03% |
| Martingale Asset Management L P | 35,266 | $408.7K | 0.01% |
| HRT Financial LP | 16,882 | $195.0K | 0.00% |
| DekaBank Deutsche Girozentrale | 15,000 | $171.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 13,246 | $153.5K | 0.00% |
| Dynamic Technology Lab Private Ltd | 12,223 | $142.0K | 0.01% |
| Principal Financial Group Inc | 10,669 | $123.7K | 0.00% |
| Virtus ETF Advisers LLC | 10,150 | $117.6K | 0.06% |
| Sphera Funds Management Ltd. | 7,149 | $82.9K | 0.03% |
| Dorsey Wright & Associates | 1,733 | $20.1K | 0.01% |
| Quantbot Technologies LP | 400 | $4.64K | 0.00% |
| Federated Hermes, Inc. | 236 | $2.73K | 0.00% |
| Nisa Investment Advisors, LLC | 45 | $1.00K | 0.00% |
| CWM, LLC | 43 | $0 | 0.00% |
Sold out (9)
Institutions that held Dyne Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Janus Henderson Group PLC | 765,953 | $9.73M |
| OrbiMed Advisors LLC | 220,400 | $2.80M |
| UBS Oconnor LLC | 176,490 | $2.24M |
| Alpha Paradigm Partners, LLC | 34,630 | $440.0K |
| Financial Management Network Inc | 40,000 | $396.0K |
| Cornercap Investment Counsel Inc | 23,601 | $300.0K |
| PDT Partners, LLC | 19,705 | $250.0K |
| HC Advisors, LLC | 14,272 | $181.0K |
| Wells Fargo & Company | 41 | $1.00K |
Not filed for Q4 2022 yet (1)
Institutions that held Dyne Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| FourThought Financial, LLC | 1,563 | $20.0K |